Bionano Genomics, Inc.
BNGONASDAQHealthcare● Active
$1.17
+$0.00(+0.00%)
Market Cap$3841591
P/E Ratio—
52W High$5.5
52W Low$1.06
Bionano Genomics, Inc.（BNGO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BNGO · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $28.51M | $30.78M | $36.12M | $27.80M | $17.98M |
| Cost of Revenue | $22.25M | $30.40M | $26.55M | $21.86M | $14.11M |
| Gross Profit | $6.26M | $0.38M | $9.57M | $5.95M | $3.87M |
| Gross Margin %(computed) | 21.95% | 1.23% | 26.49% | 21.38% | 21.54% |
| Operating Expenses | |||||
| R&D Expenses | $11.37M | $24.80M | $54.03M | $49.05M | $22.48M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $39.60M | $104.36M | $224.81M | $137.64M | $80.97M |
| Operating Income | ($33.34M) | ($103.98M) | ($215.25M) | ($131.70M) | ($77.10M) |
| Operating Margin %(computed) | -116.95% | -337.87% | -595.98% | -473.70% | -428.79% |
| Interest Income | $1.11M | $2.10M | $3.31M | $1.51M | $0.24M |
| Interest Expense | $0.30M | $0.29M | $5.12M | $0.30M | $0.93M |
| Income Before Tax | ($26.33M) | ($111.98M) | ($232.43M) | ($130.71M) | ($78.15M) |
| Income Tax Expense | $0.07M | $0.03M | $0.06M | $1.88M | ($5.72M) |
| Net Income | ($26.39M) | ($112.02M) | ($232.49M) | ($132.60M) | ($72.44M) |
| Net Margin %(computed) | -92.59% | -363.98% | -643.74% | -476.93% | -402.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.85 | $-88.13 | $-408.48 | $-267.71 | $-157.02 |
| Wtd Avg Shares | 5.45M | 1.90M | 0.58M | 0.49M | 0.47M |
| EBITDA | ($23.61M) | ($97.47M) | ($213.60M) | ($120.31M) | ($73.86M) |
| EBITDA Margin %(computed) | -82.81% | -316.70% | -591.44% | -432.76% | -410.74% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Bionano Genomics, Inc.
关于Bionano Genomics, Inc.（BNGO）损益表
Bionano Genomics, Inc.（BNGO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BNGO实现营收$0.03B，毛利润$0.01B（毛利率21.95%），净利润($0.03B)（净利率-92.59%）。
常见问题
BNGO · 4 问Bionano Genomics, Inc.（BNGO）2025财年营收为$0.03B，同比down7.4%。
BNGO revenueBNGO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08